Product analysis
Genius Test combines ingredients aimed at testosterone support, with ashwagandha also offering a possible role in stress relief. Several ingredient forms are unspecified, making it harder to compare the formula with preparations that have supporting evidence.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality31
Some plant extracts are identified, but several other forms remain unspecified. That limits a confident judgment of the formula’s quality or how closely its ingredients match particular preparations.
Ingredient Transparency79
All declared ingredient amounts are stated, which helps compare servings. Several forms are omitted, leaving important details about the exact preparations unclear.
Value For Money35
Fenugreek and boron are relatively costly by their respective comparisons. Unresolved comparisons for the other ingredients make the value of the full combination uncertain.
Customer Satisfaction70
The small number of customer ratings is strongly positive. That gives an encouraging early picture of satisfaction but leaves uncertainty about broader experience.
Product Focus65
Testosterone support is the main purpose, with more limited preparation-specific connections to stress, sleep and training. The wider range of goals does not establish that the combined formula improves each of them.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $1.93
- Customer rating
- 4.7 · 45 ratings
Goals
PrimaVie shilajit has limited hormone-marker evidence in healthy men aged 45–55, and the 500 mg serving matches that study's daily preparation mass. KSM-66 ashwagandha has an exercise-specific testosterone signal, but the 1,000 mg serving exceeds its reviewed exposure without establishing greater benefit. Generic fenugreek cannot borrow Testofen results, and LJ100 lacks verified equivalence to the reviewed tongkat preparation.
How this product is rated for Testosterone Support
Ingredient fit69
Goal fit
Dose adequacy
Pathways100
Depth
Breadth
Evidence95
Evidence strength
Studied preparation
Formulation logic94
Partner coverage
Conflicts
Effective doses
Ashwagandha receives a saved stress-fatigue contribution, but the supplied trial did not establish a significant improvement in its standard fatigue outcome. Generic extract mass cannot reproduce the trial's preparation, population or regimen. The larger amount does not establish a general energy boost.
How this product is rated for Energy
Ingredient fit59
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence71
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
KSM-66 ashwagandha has limited, preparation-specific evidence for supporting resistance-training outcomes. Its contribution depends on repeated use alongside training rather than an acute pre-workout effect. The selected serving is compared with the study exposure without assuming a daily regimen, and a larger amount does not establish greater benefit.
How this product is rated for Fitness
Ingredient fit59
Goal fit
Dose adequacy
Pathways52
Depth
Breadth
Evidence86
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ashwagandha and boron receive saved contributions in stress-related and mineral-metabolism areas. Ashwagandha's stress and insomnia findings depend on the preparation and population, so they do not establish routine broad benefit in unstressed adults. Boron research likewise does not establish general-health improvement or an essential nutrient requirement. Their declared amounts reach the saved endpoints without proving greater benefit at these exposures.
How this product is rated for Everyday Health
Ingredient fit67
Goal fit
Dose adequacy
Pathways80
Depth
Breadth
Evidence96
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ashwagandha is the ingredient most directly connected to perceived stress in this formula. Several extract trials have reported improvements, but the extract, population and duration affect applicability. The 1000 mg serving does not establish greater benefit than smaller studied amounts, and the rest of this broader formula adds no demonstrated combined stress effect.
How this product is rated for Stress Relief
Ingredient fit59
Goal fit
Dose adequacy
Pathways77
Depth
Breadth
Evidence95
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
KSM-66 ashwagandha may support sleep quality through stress-related effects, with findings drawn from repeated use over weeks. The serving contains 1,000 mg of the identified extract, above the 600 mg daily amount in the highlighted insomnia study; that difference does not establish greater benefit. Ashwagandha supplies the relevant sleep connection in this broadly focused formula. An immediate sedative effect is not established.
How this product is rated for Sleep Support
Ingredient fit59
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence74
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
KSM-66 (Ashwagandha Root Extract) | 1000 mg | |
Primavie | 500 mg | |
Fenugreek (Saponins) | 500 mg | |
Quercetin Dihydrate | 250 mg | |
3,3'-Diindolylmethane | 250 mg | |
LJ100 (Eurycoma longifolia Extract) | 100 mg | |
Boron Citrate | 10 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure100
Amount and Label Disclosure
Commercial Price and Usability20
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
- Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
- Efficacy of Withania somnifera supplementation on adult's cognition and mood.
- A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6-12 years.
- Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
- A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.
- Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
- Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study.
- Efficacy and Safety of Low-Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial.
- Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits.
- Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study.
- A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults.
- Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO 2max in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study.
- Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults.
- Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study.
- Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis.
- Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.
- Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
- The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
- Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).